AstraZeneca plc vs Charter Communications Inc — how do they compare? AstraZeneca plc trades at $158.03 (market cap $248.14B), while Charter Communications Inc trades at $156.89 (market cap $18.81B). The key difference: AstraZeneca plc is far larger — about 13.2× Charter Communications Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Charter Communications Inc pays none. Which is the better fit depends on your goals.
| AZN | CHTR | |
|---|---|---|
Market Cap | $248.14B | $18.81B |
Sector | Health | Media |
52-Week High | $209.48 | $282.74 |
52-Week Low | $147.06 | $123.31 |
Enterprise Value | $275.41B | $115.01B |
Dividend Yield | 2.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 54 million U.S. homes and businesses, around 40% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest U.S. cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.
Read more on CHTR →